Business context and reporting period
Alvarium Tiedemann Holdings, Inc. (now associated with the AlTi name) filed this Form 10-K for the fiscal year ended December 31, 2022. The issuer was then Cartesian Growth Corporation, a SPAC that had not yet completed its business combination. The transaction with Tiedemann Wealth Management Holdings, the TIG Entities and Alvarium closed on January 3, 2023; the 10-K’s audited financial statements and MD&A therefore report the pre-combination SPAC, not the combined operating business.
The filing describes the post-combination platform as a global wealth-management and financial-services business. It estimated combined assets managed or advised of approximately $65.0 billion at December 31, 2022, with about 470 professionals in 22 cities across 10 countries. The company said it would separately file the acquired businesses’ 2022 audited financial statements and related MD&A in an amendment to a Form 8-K.
Financial results, cash flow and liquidity
| Metric | FY 2022 | FY 2021 |
|---|---|---|
| SPAC operating revenue | None reported; the SPAC had not begun operating | None reported |
| Operating loss | $8.86 million | $1.01 million |
| Net income (loss) | $8.78 million | $(1.04) million |
| Net cash used in operating activities | $0.97 million | $0.91 million |
FY 2022 net income was not an operating-profit indicator: it included a $12.56 million noncash gain from the change in fair value of warrant liabilities and $4.97 million of trust-account interest, against the operating loss. The filing does not provide post-combination consolidated revenue, operating profit, margins or cash flow for the acquired businesses in this 10-K.
At December 31, 2022, the SPAC had $85,540 cash outside its trust account and a $7.92 million working-capital deficit. The trust account held $349.98 million, presented against redeemable shares; it should not be read as unrestricted operating liquidity available to the post-combination company. Management said the January 2023 business combination alleviated substantial doubt about the SPAC’s ability to continue as a going concern. The SPAC had no long-term debt obligations reported in its contractual-obligations discussion, apart from specified fees and transaction-related liabilities.
A separate market-risk disclosure lists $26.6 million of revolving borrowings and $96.6 million of term-loan borrowings at December 31, 2022 for the target businesses. It identifies variable-rate facilities and a $48.3 million Alvarium shareholder loan bearing 25% interest, repayable January 7, 2023. These are legacy target-company figures, not a post-closing consolidated debt or liquidity presentation; the filing text does not provide a clear post-combination debt balance. On January 3, 2023, the SPAC paid its $7.8 million deferred underwriting fee and repaid its $500,000 working-capital note.
Material changes and unusual items
- The January 3, 2023 business combination and $164.999 million PIPE investment occurred after year-end. PIPE investors subscribed at $9.80 per share; the filing describes bonus-share mechanics as part of the closing.
- On December 30, 2022, an Alvarium subsidiary sold its investment adviser to Home REIT for approximately £24 million, received as a promissory note due December 31, 2023, subject to possible extension.
- The issuer’s FY 2022 results changed from a loss to income largely because of trust interest and warrant-liability fair-value movements, rather than operating revenue.
- The filing reports material weaknesses in internal control over financial reporting, including the SPAC’s accounting for complex financial instruments and historical weaknesses identified at Alvarium and TWMH. The SPAC concluded its disclosure controls and procedures were ineffective at year-end.
Outlook, commentary and principal risks
The filing presents no quantified post-combination financial guidance. Management describes an intended growth strategy combining organic expansion with selective acquisitions and joint ventures, and cites recurring advisory and administration fees alongside more variable performance and transaction fees. Those are strategic descriptions, not a forecast.
Risks highlighted include market declines and inflation or rising rates affecting asset-based fees, debt costs and real estate; competition, client withdrawals and fee pressure; integration and growth execution; retention of key personnel; conflicts of interest and allocation of co-investments or expenses; extensive regulation; cybersecurity and privacy incidents; and the company’s ability to comply with debt covenants and obtain financing. The filing also discusses geopolitical risks, including the Russia-Ukraine war and U.S.-China tensions, and potential regulatory and reputational exposure.
Since November 2022, Home REIT and its then-adviser AHRA had faced allegations stemming from a short-seller report. The company states AHRA was sold before the business combination, but acknowledges potential reputational effects. It reports no material pending legal or regulatory proceedings known to the legacy businesses at the time described, while noting ordinary-course claims and regulatory exposure.
Important facts for investors to verify
- Read the separately filed audited 2022 financial statements and MD&A for TWMH, the TIG Entities and Alvarium; this 10-K’s audited statements are for the pre-combination SPAC.
- Reconcile the $65.0 billion combined AUM/AUA estimate with the acquired businesses’ definitions, billable assets and reported fee-earning assets.
- Confirm post-closing cash, debt, interest rates, covenant headroom and any refinancing needs using subsequent filings; distinguish target-company year-end debt from SPAC liabilities.
- Assess the status and remediation of the disclosed internal-control material weaknesses and review subsequent reporting for any restatement or control updates.
- Verify collection and timing of the £24 million Home REIT adviser-sale note, and monitor developments concerning Home REIT and related reputational or legal exposure.
- Review the PIPE, share-class and lock-up terms, Tax Receivable Agreement obligations, and potential dilution from warrants and unit exchanges.